KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS)
Clinical trials for KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS) explained in plain language.
Never miss a new study
Get alerted when new KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS) trials appear
Sign up with your email to follow new studies for KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study targets rare Virus-Driven inflammatory syndrome
Disease control Recruiting nowThis study looks at a newly recognized disease called KSHV Inflammatory Cytokine Syndrome (KICS), caused by a virus that can also lead to certain cancers. Researchers aim to learn more about the disease and test experimental treatments, including antiviral and chemotherapy drugs,…
Matched conditions: KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug trial targets deadly inflammation in HIV patients
Disease control Recruiting nowThis study tests a drug called pacritinib in people with HIV who have two rare conditions caused by the Kaposi sarcoma herpesvirus (KSHV): KSHV-associated multicentric Castleman disease (MCD) and KSHV inflammatory cytokine syndrome (KICS). These conditions cause severe, life-thre…
Matched conditions: KSHV INFLAMMATORY CYTOKINE SYNDROME (KICS)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC